Torno Capital »

Amylyx Pharmaceuticals shares owned by Torno Capital

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Torno Capital from 13F filings

Historical chart of Torno Capital investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Torno Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Torno Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $221k 15k 14.72

More positions owned by Torno Capital

Sprott Fds Tr Uranium Miners E Put Option (URNM)
Spotify Technology S A SHS Put Option (SPOT)
Alphabet Cap Stk Cl A (GOOGL)
Global X Fds Global X Uranium Put Option (URA)
Ishares Msci Sth Kor Etf Put Option (EWY)
Colgate-Palmolive Company Put Option (CL)
Caterpillar Call Option (CAT)
BlackRock Call Option (BLK)
Booz Allen Hamilton Hldg Cor Cl A Call Option (BAH)
United States Stl Corp New Com Put Option (X)
Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Incyte Corporation Call Option (INCY)
Realty Income Call Option (O)
Rio Tinto Sponsored Adr Call Option (RIO)
Regeneron Pharmaceuticals Put Option (REGN)

View all positions for Torno Capital

Top funds holding Amylyx Pharmaceuticals

Vanguard Group
Viking Global Investors
Point72 Asset Management
Millennium Management
Citadel Advisors
Ikarian Capital
Perceptive Advisors
Franklin Resources
Goldman Sachs Group
Jane Street
Eventide Asset Management
Jupiter Asset Management
Marshall Wace
T. Rowe Price Associates
Deutsche Bank Aktiengesellschaft

View all funds holding Amylyx Pharmaceuticals